Latham TS - Search Results

1

Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial.

Ambrose EE, Latham TS, Songoro P, Charles M, Lane AC, Stuber SE, Makubi AN, Ware RE, Smart LR. Ambrose EE, et al. Among authors: latham ts. Lancet Haematol. 2023 Apr;10(4):e261-e271. doi: 10.1016/S2352-3026(22)00405-7. Epub 2023 Mar 1. Lancet Haematol. 2023. PMID: 36870358 Free PMC article. Clinical Trial.

2

Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.

McGann PT, Tshilolo L, Santos B, Tomlinson GA, Stuber S, Latham T, Aygun B, Obaro SK, Olupot-Olupot P, Williams TN, Odame I, Ware RE; REACH Investigators. McGann PT, et al. Pediatr Blood Cancer. 2016 Jan;63(1):98-104. doi: 10.1002/pbc.25705. Epub 2015 Aug 14. Pediatr Blood Cancer. 2016. PMID: 26275071 Free PMC article.

3

Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial.

Anyanwu JN, Williams O, Sautter CL, Kasirye P, Hume H, Opoka RO, Latham T, Ndugwa C, Ware RE, John CC. Anyanwu JN, et al. JMIR Res Protoc. 2016 Jun 23;5(2):e110. doi: 10.2196/resprot.5599. JMIR Res Protoc. 2016. PMID: 27339303 Free PMC article.

4

EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.

Rankine-Mullings AE, Little CR, Reid ME, Soares DP, Taylor-Bryan C, Knight-Madden JM, Stuber SE, Badaloo AV, Aldred K, Wisdom-Phipps ME, Latham T, Ware RE. Rankine-Mullings AE, et al. JMIR Res Protoc. 2016 Sep 12;5(3):e185. doi: 10.2196/resprot.5872. JMIR Res Protoc. 2016. PMID: 27619954 Free PMC article.

5

Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia.

Jeste ND, Sánchez LM, Urcuyo GS, Bergés ME, Luden JP, Stuber SE, Latham TS, Mena R, Nieves RM, Ware RE. Jeste ND, et al. Among authors: latham ts. JMIR Res Protoc. 2017 Jun 2;6(6):e107. doi: 10.2196/resprot.7491. JMIR Res Protoc. 2017. PMID: 28576754 Free PMC article.

6

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia.

Opoka RO, Ndugwa CM, Latham TS, Lane A, Hume HA, Kasirye P, Hodges JS, Ware RE, John CC. Opoka RO, et al. Among authors: latham ts. Blood. 2017 Dec 14;130(24):2585-2593. doi: 10.1182/blood-2017-06-788935. Epub 2017 Oct 19. Blood. 2017. PMID: 29051184 Free article. Clinical Trial.

7

Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.

McGann PT, Williams TN, Olupot-Olupot P, Tomlinson GA, Lane A, Luís Reis da Fonseca J, Kitenge R, Mochamah G, Wabwire H, Stuber S, Howard TA, McElhinney K, Aygun B, Latham T, Santos B, Tshilolo L, Ware RE; REACH Investigators. McGann PT, et al. Am J Hematol. 2018 Aug;93(4):537-545. doi: 10.1002/ajh.25034. Epub 2018 Jan 27. Am J Hematol. 2018. PMID: 29318647 Free PMC article. Clinical Trial.

8

Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.

Tshilolo L, Tomlinson G, Williams TN, Santos B, Olupot-Olupot P, Lane A, Aygun B, Stuber SE, Latham TS, McGann PT, Ware RE; REACH Investigators. Tshilolo L, et al. Among authors: latham ts. N Engl J Med. 2019 Jan 10;380(2):121-131. doi: 10.1056/NEJMoa1813598. Epub 2018 Dec 1. N Engl J Med. 2019. PMID: 30501550 Free PMC article. Clinical Trial.

9

Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial.

Sánchez LM, Nieves RM, Latham T, Stuber S, Luden JR, Urcuyo GS, Berges ME, Florencio C, Gonzalez C, Del Villar P, Lane A, Schultz W, Jeste N, Mena R, Ware RE. Sánchez LM, et al. Blood Adv. 2018 Nov 30;2(Suppl 1):50-53. doi: 10.1182/bloodadvances.2018GS110818. Blood Adv. 2018. PMID: 30504201 Free PMC article. Clinical Trial. No abstract available.

10

Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort.

Opoka RO, Hume HA, Latham TS, Lane A, Williams O, Tymon J, Nakafeero M, Kasirye P, Ndugwa CM, John CC, Ware RE. Opoka RO, et al. Among authors: latham ts. Haematologica. 2020 Jun;105(6):e272-e275. doi: 10.3324/haematol.2019.231407. Epub 2019 Oct 24. Haematologica. 2020. PMID: 31649130 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters